Pasar al contenido principal

ENZIMAS EN HIDROGELES NANOCOMPUESTOS COMO PLATAFORMAS DE BIODETECCION Y BIOCATALISIS: APLICACION AL DESCUBRIMIENTO Y DEGRADACION DE FARMACOS

PID2022-138507OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Design of an Electrochemical Device for the detection of Alkaline Phosphatase Inhibitors in Seawater

  • Sáenz-Espinar, Maria J.
  • Hafed-Khatiri, Salma
  • Salinas-Torres, David
  • Montilla, Francisco
  • Huerta, Francisco|||0000-0002-9791-0355
[EN] The present contribution describes an electrochemical system for the detection of alkaline phosphatase (ALP) enzyme inhibitors in seawater medium. Fluorescence spectroscopy and thermal unfolding results suggest that the state of free ALP is affected in this medium, yet the protein remains active. The enzyme activity can be evaluated using hydroquinone diphosphate as the substrate, with hydroquinone as the electrochemically monitored product. It has been demonstrated that encapsulation in conventional and organic modified silica matrices maintains ALP integrity, although diffusion across the formed monoliths hinders the electrochemical response. ALP@Phenyl-modified silica exhibits the best performance due to higher affinity between substrate molecules and aromatic moieties and, probably, to larger pore size. This electrochemical system can detect and quantify calyculin A in seawater at sub-nanomolar concentrations and it can also be employed for the development of electrochemical biosensors tailored for the marine environment., The authors greatly acknowledge PhD. Andrés F. QuinteroJaime for his outstanding contributions to this research in the form of critical key comments on the methods and experimental results, supported by his deep knowledge on sensing devices. Financial support by Spanish Ministry of Science (TED2021-129894B-I00 and PID2022-138507OB-I00 projects), Generalitat Valenciana (GVA-THINKINAZUL/2021/ 015, MFA/2022/058 and CIPROM/2021/62 projects) and European Union (NextGenerationEU PRTR-C17.I1) is gratefully acknowledged.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Electrochemical biosensor on disposable electrodes for the detection of alkaline phosphatase inhibitors in seawater

  • Sáenz-Espinar, María J.
  • Montilla, Francisco
  • Huerta, Francisco|||0000-0002-9791-0355
[EN] A disposable electrochemical biosensor for the detection of alkaline phosphatase (ALP) inhibitors in seawater was developed by immobilizing ALP within sol-gel silica and organically modified silica matrices deposited onto screen-printed carbon electrodes. Hydroquinone diphosphate, an electroinactive substrate, enabled amperometric quantification of enzymatic activity through the electrochemical detection of the hydrolysis product, hydroquinone. Fluorescence spectroscopy confirmed that ALP retained its structural integrity after immobilization, although restricted rotational mobility and microenvironmental polarity shifts were observed depending on the silica modifier. All matrices allowed substrate and product diffusion, although reduced apparent activity is detected relative to the free enzyme, because of diffusional constraints. Among the materials tested, isobutylmodified silica provided the optimal balance between structural stabilization and catalytic accessibility, yielding the highest apparent activity. Inhibition assays using phosphate ion demonstrated a clear dosedependent suppression of enzymatic activity, with a linear response from 1 to 10 mu M and a limit of detection of 0.38 mu M. The biosensor exhibits rapid response, portability, and suitability for in situ assessment of phosphate and other ALP-inhibiting contaminants in marine environments., Financial support by Spanish Ministry of Science (TED2021-129894B-I00 and PID2022-138507OB-I00 projects) , Generalitat Valenciana (GVA-THINKINAZUL/2021/015, MFA/2022/058 and CIPROM/2021/62 projects) and European Union (NextGenerationEU PRTR-C17.I1) is gratefully acknowledged.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Harnessing the power of thermosensitive liposomes with gold nanoprisms and silica for controlled drug delivery in combined chemotherapy and phototherapy

  • Rubio-Camacho, Marta
  • Cuestas-Ayllón, Carlos
  • Torres Herrero, Beatriz
  • Martínez-Tomé, María José
  • Fuente, Jesús M. de la
  • Reyes Mateo, C.
In recent years, the scientific community has tried to address the treatment of complex diseases such as cancer in a more appropriate and promising way. Regarding this and benefiting from the unique optical properties of gold nanoprisms (AuNPRs), the physicochemical properties of thermosensitive liposomes (TSLs), and the tunable drug encapsulation and release properties of silica nanoparticles (BioSi@NPs), this study has developed two nanoformulations. These nanoformulations have the potential to integrate chemotherapy and photothermal therapy within a single entity. Once their components were synthesized and characterized separately, two strategies were taken in order to develop these multifunctional nanoformulations: (1) covalent binding of AuNPRs to TSLs and (2) co-encapsulation of both components within BioSi@NPs, without modifying the optical and physicochemical properties of AuNPRs and TSLs. Finally, the suitability of both nanoformulations to carry and release hydrophilic drugs when triggered by a 1064 nm NIR laser has been explored by using the fluorescent probe 5(6)-carboxyfluorescein (CF) as a hydrophilic drug model. Different laser power and time of exposure were also tested evidencing that hydrophilic drugs were only released from TSLs in the presence of AuNPRs and that the drug release profile was dependent on the type of nanoformulation and irradiation conditions used. In conclusion, these multifunctional nanoformulations exhibit promising potential for controlled drug delivery in combined chemotherapy and phototherapy, with the capability to precisely control the release kinetics based on specific therapeutic needs., This work was supported by the projects PID2022-138507OB-I00 (funded by MICIU/AEI/10.13039/501100011033 and ERDF, EU), CIAICO/2022/131 (funded by Generalitat Valenciana) and PID2020-118485RB-I00 (funded by Agencia Estatal de Investigación). In addition, M. R.-C. acknowledges her predoctoral fellowship (ACIF/2018/226) and mobility grant (BEFPI/2021/083) funded by the Generalitat Valenciana, Conselleria d’Educació, Investigació, Cultura I Esport. B. T.-H. also acknowledges her financial support to the DGA Fellowship program (December 2019–November 2020) and to the predoctoral fellowship (FPU19/01311) funded by MCIN/AEI/10.13039/501100011033 and “ESF Investing in your future”. Authors also acknowledge support from Gobierno de Aragón and Fondos Feder for funding the Bionanosurf (E15_23R) research group. The authors would like to acknowledge the use of the Advanced Microscopy Laboratory (Universidad de Zaragoza), for access to their instrumentation and expertise and the use of Servicio General de Apoyo a la Investigación-SAI, Universidad de Zaragoza., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Harnessing the power of thermosensitive liposomes with gold nanoprisms and silica for controlled drug delivery in combined chemotherapy and phototherapy

  • Rubio-Camacho, Marta
  • Cuestas-Ayllón, Carlos
  • Torres-Herrero, Beatriz
  • Martínez-Tomé, María José
  • Martínez de la Fuente, Jesús
  • Mateo, C. Reyes
In recent years, the scientific community has tried to address the treatment of complex diseases such as cancer in a more appropriate and promising way. Regarding this and benefiting from the unique optical properties of gold nanoprisms (AuNPRs), the physicochemical properties of thermosensitive liposomes (TSLs), and the tunable drug encapsulation and release properties of silica nanoparticles (BioSi@NPs), this study has developed two nanoformulations. These nanoformulations have the potential to integrate chemotherapy and photothermal therapy within a single entity. Once their components were synthesized and characterized separately, two strategies were taken in order to develop these multifunctional nanoformulations: (1) covalent binding of AuNPRs to TSLs and (2) co-encapsulation of both components within BioSi@NPs, without modifying the optical and physicochemical properties of AuNPRs and TSLs. Finally, the suitability of both nanoformulations to carry and release hydrophilic drugs when triggered by a 1064 nm NIR laser has been explored by using the fluorescent probe 5(6)-carboxyfluorescein (CF) as a hydrophilic drug model. Different laser power and time of exposure were also tested evidencing that hydrophilic drugs were only released from TSLs in the presence of AuNPRs and that the drug release profile was dependent on the type of nanoformulation and irradiation conditions used. In conclusion, these multifunctional nanoformulations exhibit promising potential for controlled drug delivery in combined chemotherapy and phototherapy, with the capability to precisely control the release kinetics based on specific therapeutic needs.